Oral Agents in Multiple Sclerosis

E-ISSN： 1875-614x|14|1|15-25

ISSN： 1871-5230

Source： Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol.14, Iss.1, 2015-03, pp. : 15-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oral Therapies for Multiple Sclerosis: A Review of Agents in Phase III Development or Recently Approved

By Gold Ralf

CNS Drugs, Vol. 25, Iss. 1, 2011-01 ,pp. : 37-52

Adis International

Access to resources Recommend Favorite

Novel therapeutic agents for multiple sclerosis

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 12, 1999-12 ,pp. : 1739-1741

Informa Healthcare

Access to resources Recommend Favorite

Teriflunomide for oral therapy in multiple sclerosis

By Papadopoulou Athina Kappos Ludwig Sprenger Till

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 617-628

Informa Healthcare

Access to resources Recommend Favorite

Oral drugs for the treatment of Multiple Sclerosis

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 396-402

Govi-Verlag

Access to resources Recommend Favorite

Estrogens as Potential Therapeutic Agents in Multiple Sclerosis

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 87-94

Bentham Science Publishers

Access to resources Recommend Favorite